New Therapeutic Options for Fragile X Syndrome

Current Treatment Options in Neurology
Isha JalnapurkarJean A Frazier

Abstract

The purpose of this review is to provide an overview of current research and clinical practice guidelines in fragile X syndrome (FXS) with regard to therapeutic approaches in the management of this condition. The authors summarize and discuss findings from relevant preclinical studies and results from clinical trials in human subjects with FXS. Additionally, we provide an outline of the basic framework for understanding and providing educational and psychosocial supports for these individuals. Current treatments in FXS are largely symptom based and focused on managing associated psychiatric and behavioral co-morbidities. While data from animal studies has been promising in providing targeted treatments to correct the underlying deficits at the cellular level, there have not been as robust findings in human trials. There are several targeted treatments for FXS currently under development. Individuals with FXS present with several behavioral challenges including anxiety, social withdrawal, ADHD, hyperarousal, self-injury, and aggression. Therapeutic services are often necessary, such as behavioral intervention, speech and language therapy, occupational therapy, and individualized educational support; adjunctive psychopharmacologi...Continue Reading

References

May 1, 1988·American Journal of Medical Genetics·R J HagermanM D Wittenberger
Jan 1, 1994·European Journal of Clinical Investigation·F Rousseau
Nov 1, 1996·Archives of General Psychiatry·C J McDougleL H Price
Jul 8, 1998·Journal of Anxiety Disorders·C L TurkM R Liebowitz
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimberly M HuberMark F Bear
Jul 11, 2002·Human Genetics·Rob WillemsenBen A Oostra
Mar 3, 2004·Mental Retardation and Developmental Disabilities Research Reviews·Elizabeth Berry-Kravis, Kristina Potanos
Jun 29, 2004·Trends in Neurosciences·Mark F BearStephen T Warren
Aug 25, 2004·American Journal of Medical Genetics. Part a·Walter E KaufmannPia Stanard
Mar 10, 2005·European Child & Adolescent Psychiatry·Antonina Ingrassia, Jeremy Turk
Mar 3, 2006·Journal of Developmental and Behavioral Pediatrics : JDBP·Randi J Hagerman
Oct 6, 2006·American Journal of Medical Genetics. Part a·Kelly SullivanDonald Bailey
Dec 21, 2007·Neuron·Gül DölenMark F Bear
Jan 5, 2008·American Journal of Mental Retardation : AJMR·Scott S HallAllan L Reiss
Aug 14, 2008·Journal of Developmental and Behavioral Pediatrics : JDBP·Elizabeth Berry-KravisWilliam T Greenough
Jan 2, 2009·Pediatrics·Randi J HagermanMichael Tranfaglia
Jan 8, 2009·Journal of Medical Genetics·E Berry-KravisR Hagerman
Jan 9, 2009·American Journal of Mental Retardation : AJMR·Susan W HarrisRandi J Hagerman
Jul 18, 2009·Journal of Autism and Developmental Disorders·Craig A EricksonChristopher J McDougle
Dec 9, 2009·Advances in Pediatrics·Weerasak ChonchaiyaRandi J Hagerman
Mar 10, 2010·Journal of Autism and Developmental Disorders·Craig A EricksonChristopher J McDougle
Jul 21, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Craig A EricksonChristopher J McDougle
Jul 28, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jose Luis Olmos-SerranoMolly M Huntsman
Aug 7, 2010·American Journal on Intellectual and Developmental Disabilities·Agustini UtariDanh V Nguyen
Sep 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Feng PanWen-Biao Gan
May 10, 2011·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Carlos Portera-Cailliau
Jun 15, 2011·Journal of Neurodevelopmental Disorders·Jane E RobertsDeborah D Hatton
Aug 19, 2011·The Journal of Pharmacology and Experimental Therapeutics·Lothar LindemannJoseph G Wettstein
Jan 31, 2012·Behavioural Brain Research·Inge HeulensR Frank Kooy
Apr 17, 2012·Neuron·Aubin MichalonLothar Lindemann
May 1, 2012·Neuron·Ivan IossifovMichael Wigler
Aug 18, 2012·International Journal of Pediatrics·Elizabeth Berry-KravisShaguna Mathur

❮ Previous
Next ❯

Citations

Jan 16, 2021·Psychopharmacology·Craige C WrennMaria G Valdovinos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Related Papers

Intractable & Rare Diseases Research
Andrew Ligsay, Randi J Hagerman
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Christina GrossElizabeth Berry-Kravis
© 2022 Meta ULC. All rights reserved